Parker-Hannifin Earnings Call Transcripts
Fiscal Year 2027
-
Q3 sales rose 10% YoY, adjusted EPS increased 40%, and orders strengthened across industrial markets. FY2017 guidance was raised, with CLARCOR integration and debt reduction central to the outlook.
Fiscal Year 2026
-
FY2026 set records, with sales exceeding $20 billion and the FY2029 adjusted segment margin target reached three years early. Shareholders elected all nominees, approved advisory executive compensation, and ratified Deloitte & Touche for FY2027.
-
Record FY 2026 results included $21.5B in sales, 18% EPS growth, and record margins. FY 2027 guidance calls for 7% organic growth, 27.7% margin, and $34.75 EPS, with all market verticals expected to grow. Major acquisitions and a new 30% margin target by FY 2031 were announced.
-
Record Q3 results with 11% sales growth, 18% EPS increase, and robust cash flow. Aerospace and transportation segments led performance, with strong order growth and record backlogs. FY 2026 guidance raised for sales, margins, and EPS, supported by resilient demand and disciplined execution.
-
The company delivers strong financial performance, driven by its Win Strategy, decentralized structure, and focus on high-growth segments like aerospace and aftermarket. Recent and pending acquisitions, including Curtis and Filtration Group, are expected to enhance capabilities. Industrial markets are recovering, with robust international growth and operational improvements.
-
Aerospace continues to drive record growth and margins, while industrial markets show gradual recovery, especially in North America and Asia. Strategic acquisitions, operational excellence, and disciplined investment underpin strong financial targets and future innovation, with filtration set to become a major business vertical.
-
Sales are guided to $21 billion with balanced exposure across aerospace and industrial segments. Margin expansion and EPS growth have been driven by internal strategy and acquisitions, with further gains expected as backlog and automation investments rise. M&A and disciplined capital allocation remain key priorities.
-
Record Q2 results with 9% sales growth, 27.1% segment margin, and 17% EPS increase. Guidance raised for sales, margins, and EPS, supported by strong order rates, record backlog, and the strategic Filtration Group acquisition. Aerospace, off-highway, and international segments led growth.
-
Record Q1 results featured 5% organic growth, 16% EPS increase, and strong margin expansion. Guidance for FY26 was raised across sales, margins, EPS, and free cash flow, supported by robust aerospace and industrial performance and the Curtis acquisition.
Fiscal Year 2025
-
The acquisition adds complementary filtration technologies, expanding presence in key markets and creating a $5B global filtration business. $220M in cost synergies are targeted, with rapid deleveraging and accretive financials expected. Strong cultural fit and proven integration strategy support long-term growth.
-
The meeting featured the election of ten directors, approval of executive compensation, and ratification of the auditor, with all proposals passing. Fiscal 2025 saw record performance and progress toward long-term targets, while strategic initiatives focus on growth and efficiency.
-
Operational excellence is driven by the Win Strategy, decentralized management, and a robust distributor network, supporting margin expansion and resilient growth. M&A and innovation have transformed the portfolio, with aerospace and defense segments showing strong momentum and a healthy backlog.
-
Record FY 2025 with $19.9B sales, 26.1% margin, and $3.8B cash flow. FY 2026 guidance targets 2%-5% sales growth, 3% organic growth, and 6% EPS increase, with aerospace leading at 8% growth. Curtis Instruments acquisition to enhance electrification and EPS.
-
Record Q3 margins and cash flow were achieved despite a 2% sales decline, with aerospace driving growth and backlog. FY25 guidance was raised for aerospace and margins, while industrial and energy outlooks were lowered. Tariff impacts are fully mitigated through pricing and supply chain actions.
-
Revised summary: The company is focused on operational excellence, innovation, and portfolio transformation, targeting 4-6% organic growth and higher margins by FY2029. Growth is driven by secular trends, disciplined M&A, and strong aerospace and industrial positions, with continued cost control and a positive outlook for shareholder value.
-
Sales approach $20B with a diversified mix and strong aerospace growth. Margin expansion, robust distribution, and disciplined M&A drive performance. Confident outlook with targets for continued EPS growth and recovery in industrial markets.
-
Industrial orders have turned positive after a prolonged decline, with aerospace and select international markets driving robust growth. Margin expansion continues through the Win Strategy and recent acquisitions, while free cash flow and disciplined M&A support long-term targets.
-
Portfolio transformation has increased aerospace and technology platform exposure, driving margin and revenue growth. Industrial orders have turned positive, with recovery expected to be gradual. Margin expansion is driven by lean practices, and M&A remains disciplined, focusing on fit and technology.
-
Record Q2 margins and EPS were achieved despite a slight sales decline, driven by strong aerospace and operational execution. Guidance was raised for margins and aerospace growth, with continued debt reduction and robust cash flow. Industrial recovery is delayed but orders are turning positive.
-
Record Q1 results featured 1.4% organic sales growth, 80 bps margin expansion, and 4% EPS growth, led by aerospace strength. FY 2025 guidance was raised for margins and EPS, with divestitures expected to be margin-accretive and strong cash flow supporting further debt reduction.
Fiscal Year 2024
-
The company reported strong financial growth, driven by a diversified portfolio, resilient supply chain, and strategic focus on longer-cycle markets. Aerospace and industrial segments show robust performance, with positive channel sentiment and ongoing M&A and distribution expansion.
-
The meeting covered director elections, executive compensation, and auditor ratification, with all proposals approved. Record financial results for 2024 and new targets for 2029 were highlighted, alongside ongoing strategic initiatives and a Q&A session.
-
The session highlighted a strategic shift toward longer-cycle businesses, with Aerospace now a key growth driver and record backlog supporting strong FY25 guidance. Financial targets were raised, M&A remains a priority, and operational discipline underpins margin expansion.
-
Record FY2024 results featured strong aerospace growth, margin expansion, and robust cash flow. FY2025 guidance anticipates continued aerospace strength, gradual industrial recovery, and further margin gains, with ongoing portfolio optimization and disciplined capital allocation.
Fiscal Year 2023
Fiscal Year 2022
Fiscal Year 2021
Fiscal Year 2020
Fiscal Year 2019
Fiscal Year 2018
Fiscal Year 2017
-
Q4 sales rose 18% to $3.5B and adjusted EPS grew 29% to $2.45. FY18 guidance targets 11.4%–15% sales growth and $8.45–$9.15 adjusted EPS, supported by organic growth, simplification and CLARCOR synergies.
-
Q2 adjusted EPS rose 26% YoY and adjusted segment margin reached a record 14.7%, despite lower sales. Orders improved, supporting higher second-half organic growth guidance; currency and uneven end-market recovery remained key constraints.
-
Q1 sales declined 4% YoY, but orders turned positive and adjusted EPS rose 6% to $1.61. FY17 guidance was maintained amid weak but stabilizing markets and continued margin and cash discipline.
Fiscal Year 2016
-
Q4 adjusted EPS rose 33% YoY and adjusted margins improved despite weak industrial markets. FY2017 guidance calls for flat sales, higher adjusted margins and EPS midpoint of $6.75, supported by restructuring savings.
-
Q3 sales and adjusted EPS declined amid weak markets, but adjusted margins improved and order declines moderated. FY16 adjusted EPS guidance rose to $6.20–$6.40, supported by restructuring savings and cost discipline.
-
Q2 sales and orders weakened sharply, but adjusted margins held up through restructuring and cost controls. FY16 adjusted EPS guidance midpoint remained $6.10, with weaker second-half organic growth now expected.
-
Q1 sales and orders weakened amid currency and end-market pressures, but adjusted margins held at 15.3%. FY16 adjusted EPS guidance was cut to $5.80–$6.40, with cost actions and restructuring savings supporting profitability.
Fiscal Year 2015
-
FY 2015 sales fell 4% as currency offset flat organic growth, while adjusted margins improved to 14.9%. FY 2016 guidance anticipates slightly lower sales, higher margins and adjusted EPS of $6.65–$7.35, supported by cost actions.
-
Q3 sales declined 6%, largely from currency, while adjusted EPS rose 10% to $2.06. Weak orders, end markets and FX prompted lower FY15 adjusted EPS guidance of $7.55–$7.75.
-
Record Q2 results featured 42% adjusted EPS growth and 4% orders growth, despite significant currency pressure. FY15 adjusted EPS guidance rose to $7.90–$8.30, with adjusted segment margin forecast at 15.6%–15.9%.
-
Q1 sales reached a record $3.3B, adjusted EPS rose 13% to $1.89, and segment margins improved on restructuring and volume. FY adjusted EPS guidance rose to $7.45–$8.05, with currency headwinds partly offsetting stronger results.
Fiscal Year 2014
-
FY14 delivered record sales, higher adjusted EPS and 15% Q4 adjusted segment margins despite significant restructuring costs. FY15 guidance targets $7.25–$8.05 adjusted EPS and 15.2%–15.9% adjusted segment margins, with growth and restructuring execution risks.
-
Q3 adjusted EPS rose 11% to $1.88, orders increased 7%, and FY2014 adjusted EPS guidance rose to $6.40–$6.60. Restructuring costs increased, while operating trends and demand strengthened across many markets.
-
Adjusted EPS was $1.24, above guidance, with 3.1% organic sales growth and orders up 5%. FY14 adjusted EPS guidance stayed at $6.20-$6.60, with H2 growth expected to outpace H1 amid restructuring and a gradual recovery.
-
Q1 orders turned positive, rising 5% YoY, while segment margins held at 14.4%. FY14 EPS guidance rose to $7.78–$8.38, including the JV gain and restructuring charges; management cited moderate market improvement ahead.
Fiscal Year 2013
-
FY2013 revenue declined 1% and diluted EPS fell 16% amid soft markets and lower volume. FY2014 EPS guidance is $7.35–$8.15, including a GE Aviation JV gain, while restructuring aims to restore 15% segment margins by FY2015.
-
Q3 EPS was $1.68 and segment margin was 14% amid declining organic sales and weak orders. FY13 EPS guidance remained at a $6.45 midpoint, with early April orders and planned Q4 revenue improvement supporting the outlook.
-
Q2 revenue was flat as acquisition growth offset organic contraction, while EPS fell 24% and margins narrowed. FY2013 EPS guidance was maintained, with modest second-half improvement anticipated.
-
Q1 sales were flat at $3.2B, while EPS fell 18% to $1.57 amid international weakness and September order resets. FY13 EPS guidance was cut to $6.15–$6.75; management assumed subdued conditions would persist, while continuing acquisitions and cost actions.
Fiscal Year 2012
-
FY12 delivered record sales, earnings and segment margins, with strong cash generation. FY13 guidance calls for modest EPS growth as higher pension expense offsets much of the expected operating improvement, amid uncertain global markets.
-
Q3 revenue grew 5%, EPS reached a record $2.01 and segment margin hit 15.1%. FY2012 EPS guidance rose to $7.30–$7.50, while international markets remained soft and North America led growth.
-
Q2 set records for sales, net income, EPS and segment margin, with 8% organic growth. FY EPS guidance was reset to $6.90-$7.30 as international weakness and FX weighed, offset by North American strength.
-
Record Q1 sales, margins, net income and EPS supported a higher FY12 EPS midpoint of $7.55. Broad North American and European demand offset softer Asia and seasonal Q2 pressures.